Please login to the form below
biopharma
This page shows the latest biopharma news and features for those working in and with pharma, biotech and healthcare.
Shire rebuffs Takeda bids, as Allergan bows out
AbbVie offered $55bn for the biopharma in 2014, but the transaction was abandoned after the US introduced new measures to discourage tax inversion deals.
Latest news
-
Novo Nordisk pays $400m for EpiDestiny’s sickle cell drug
Novo Nordisk has bolstered its biopharma unit with a global licensing deal for a small-molecule drug for genetic blood disorders sickle cell disease and beta thalassaemia. ... The deal gives Novo Nordisk a new pipeline candidate at a time when its
-
Takeda mulls bid for Irish biopharma Shire
Takeda mulls bid for Irish biopharma Shire. The Japanese pharma firm must make a formal offer by 25 April. ... Takeda, Japan’s largest pharmaceutical company by sales, has announced that it’s considering a possible takeover deal for Shire, a
-
Merck KGaA inks deal for Medisafe adherence app
Steve Sturge, chief operating officer at Merck’s biopharma business, said that offering Medisafe’s platform to patients “has the potential to significantly improve medication adherence by giving patients and carers
-
Takeda’s Alofisel becomes Europe’s first allogeneic stem cell therapy
Alofisel, which works by a local administration of allogeneic expanded adipose-derived stem cells (eASCs), was initially manufactured at Belgian biopharma TiGenix, which entered into a licensing agreement with Takeda.
-
Ex-GSK CEO Witty named head of pharmacy benefit firm Optum
The PBM serves around 300 health plans - estimated to be the third-largest in the US after Express Scripts and CVS Health - and like its peers has enormous leverage on biopharma
More from news
Approximately 8 fully matching, plus 400 partially matching documents found.
Latest Intelligence
-
Accelerating diagnosis in rare disease
Accelerating diagnosis in rare disease. Timely diagnosis in rare disease is one of the fundamental unmet needs for patients, healthcare professionals (HCPs) and biopharma.
-
Accelerating diagnosis in rare disease
Accelerating diagnosis in rare disease. Timely diagnosis in rare disease is one of the fundamental unmet needs for patients, healthcare professionals (HCPs) and biopharma.
-
Communication is the key to the participatory medicine model
Healthcare systems are in need of external support to speed-up best practice adoption, with biopharma ideally placed to assist. ... Biopharma can play a key role in providing training for physicians that coaches them on optimal patient communication
-
Bridging pharma’s digital gap
Naomi O’Connell, Shire’s head of advertising and promotion, global operations, admits that the digitisation process needs to improve throughout the biopharma industry.
-
Significant figures
It all seems a long way from 2014’s disappointing news for the biopharma when ALIS failed to meet its primary endpoint in a phase II trial.
More from intelligence
Approximately 0 fully matching, plus 61 partially matching documents found.
Latest appointments
-
Abeona Therapeutics names CEO
Rare genetic disease focused biopharma Abeona Therapeutics has named its chief executive officer in the form of Carsten Thiel. ... Following a 25-year career in the biopharmaceutical industry, Thiel has held numerous roles for several biopharma’s
-
Dermavant strengthens executive team
Alongside Rubenstein, Richard Peterson joins the biopharma as its chief financial officer. ... Jasie has joined the biopharma from Codiak BioSciences, where he served as chief business officer and prior to that, he served in various executive roles at
-
Ipsen bolsters leadership team
Ipsen bolsters leadership team. Ivana Magovcevic-Liebisch and Régis Mulot join the biopharma. ... With over 20 years of senior management service experience in biopharma, Magovcevic-Liebisch joins Ipsen from Axcella Health, where she served as executive
-
Nabriva Therapeutics appoints chief medical officer
Nabriva Therapeutics, a biopharma focused on treating bacterial infections, has appointed a new chief medical officer in the form of Jennifer Schranz. ... Dr Schranz joins Nabriva from Irish biopharma Shire, with nearly two decades of experience in
-
Hansa Medical poaches Vifor Pharma’s CEO
Hansa Medical poaches Vifor Pharma’ s CEO. Søren Tulstrup becomes the Swedish biopharma’s CEO and president. ... Ulf Wiinberg, chairman at Hansa Medical, said: “Søren is an accomplished life science industry executive, who brings diverse and
More from appointments
Approximately 8 fully matching, plus 127 partially matching documents found.
Latest from PMHub
-
Immunotherapies in oncology: the future of cancer treatment lies in combinations and partnerships
Immunotherapies in oncology: the future of cancer treatment lies in combinations and partnerships. Anne Legendre reviews the scientific rationale behind immunotherapy combinations and Frances Hendry examines how partnerships, co-marketing and
-
Preparing for biopharma marketing in 2020 and beyond - Who is the marketer of the future?
Preparing for biopharma marketing in 2020 and beyond - Who is the marketer of the future? ... Who is the Marketer of the Future? Preparing for Biopharma Marketing in 2020 and Beyond.
-
Delivering on what matters to patients
there when I need you?” In other words, are biopharma companies really present in ways that truly matter to patients and in places where patients want them to be? ... If the statement “ Not everything that matters can be measured, and not everything
-
White paper download: Creating a patient-led brand strategy
To survive in an increasingly competitive marketplace, biopharma companies need to create strong, patient-centric brands that differentiate themselves from their competitors and convince the payer, physician and patient of their
-
Deal Tectonics: at the fault line of growth goals and competitive pressures
The EY Firepower Index measures biopharma companies' ability to fund M&A transactions based on the strength of their balance sheets and their market capitalization.
More from PMHub
Approximately 1 fully matching, plus 16 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Great salary and benefits
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Account Manager – Med Comms – London
-
Salary TBC
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
-
Senior Medical Writer
-
Great salary and bebefits
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
-
Senior Programme Executive
-
Salary TBC
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
-
Scientific Director
-
Great salary and bebefits
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
Subscribe to our email news alerts
- BenevolentAI raises $115m to fund drug development
- Shire rebuffs Takeda bids, as Allergan bows out
- Abeona Therapeutics names CEO
- Zelluna Immunotherapy appoints chief technology officer
- Spirit Health Group offers new market access consultancy service
- Why heading online for scientific meetings can yield greater HCP engagement
PMHub
Grace Communications
Grace Communications is a creative agency specialising in healthcare communication and understanding people's personality types....
Latest intelligence
- Why heading online for scientific meetings can yield greater HCP engagement
- Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
- Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
- Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Quick links
Infographics
